{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:33:21Z","timestamp":1793039601191,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,3,16]],"date-time":"2019-03-16T00:00:00Z","timestamp":1552694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s12325-019-00924-7","type":"journal-article","created":{"date-parts":[[2019,3,16]],"date-time":"2019-03-16T20:03:43Z","timestamp":1552766623000},"page":"1075-1084","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Bloating and Abdominal Distension: Clinical Approach and Management"],"prefix":"10.1007","volume":"36","author":[{"given":"Amir","family":"Mari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi","family":"Abu Backer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmud","family":"Mahamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Amara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doron","family":"Boltin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram","family":"Dickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,16]]},"reference":[{"issue":"6","key":"924_CR1","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","volume":"150","author":"B Lacy","year":"2016","unstructured":"Lacy B, Mearin F, Chang L, et al. Bowel disorders. Gastroenterology. 2016;150(6):1393\u2013407.","journal-title":"Gastroenterology"},{"key":"924_CR2","first-page":"242","volume-title":"Pathophysiology, diagnosis, management","author":"F Azpiroz","year":"2015","unstructured":"Azpiroz F. Intestinal gas. In: Feldman M, Friedman LS, Brand LJ, editors. Pathophysiology, diagnosis, management. Philadelphia: Elsevier; 2015. p. 242\u201350."},{"issue":"5","key":"924_CR3","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1111\/j.1572-0241.2007.01755.x","volume":"103","author":"A Tuteja","year":"2008","unstructured":"Tuteja A, Talley N, Joos S, Tolman K, Hickam D. Abdominal bloating in employed adults: prevalence, risk factors, and association with other bowel disorders. Am J Gastroenterol. 2008;103(5):1241\u20138.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"924_CR4","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1023\/A:1005554103531","volume":"45","author":"RS Sandler","year":"2000","unstructured":"Sandler RS, Stewart WF, Liberman JN, Ricci JA, Zorich NL. Abdominal pain, bloating, and diarrhea in the United States: prevalence and impact. Dig Dis Sci. 2000;45(6):1166\u201371.","journal-title":"Dig Dis Sci"},{"issue":"6","key":"924_CR5","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1136\/gut.2007.142810","volume":"57","author":"X Jiang","year":"2008","unstructured":"Jiang X, Locke G, Choung R, Zinsmeister A, Schleck C, Talley N. Prevalence and risk factors for abdominal bloating and visible distention: a population-based study. Gut. 2008;57(6):756\u201363.","journal-title":"Gut"},{"issue":"6","key":"924_CR6","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1053\/j.gastro.2016.02.032","volume":"150","author":"D Drossman","year":"2016","unstructured":"Drossman D. Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV. Gastroenterology. 2016;150(6):1262\u201379.","journal-title":"Gastroenterology"},{"issue":"12","key":"924_CR7","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1111\/j.1572-0241.2001.05336.x","volume":"96","author":"L Chang","year":"2001","unstructured":"Chang L, Lee O, Naliboff B, Schmulson M, Mayer E. Sensation of bloating and visible abdominal distension in patients with irritable bowel syndrome. Am J Gastroenterol. 2001;96(12):3341\u20137.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"924_CR8","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1053\/j.gastro.2005.06.062","volume":"129","author":"F Azpiroz","year":"2005","unstructured":"Azpiroz F, Malagelada J. Abdominal bloating. Gastroenterology. 2005;129(3):1060\u201378.","journal-title":"Gastroenterology"},{"key":"924_CR9","first-page":"2044","volume":"88","author":"F Fern\u00e1ndez-Ba\u00f1ares","year":"1993","unstructured":"Fern\u00e1ndez-Ba\u00f1ares F, Esteve-Pardo M, de Leon R, et al. Sugar malabsorption in functional bowel disease: clinical implications. Am J Gastroenterol. 1993;88:2044\u2013205.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"924_CR10","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1053\/j.gastro.2009.01.067","volume":"136","author":"A Accarino","year":"2009","unstructured":"Accarino A, Perez F, Azpiroz F, Quiroga S, Malagelada J. Abdominal distention results from caudo-ventral redistribution of contents. Gastroenterology. 2009;136(5):1544\u201351.","journal-title":"Gastroenterology"},{"issue":"2","key":"924_CR11","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1469-7793.1998.579bw.x","volume":"506","author":"J Serra","year":"1998","unstructured":"Serra J, Azpiroz F, Malagelada J. Modulation of gut perception in humans by spatial summation phenomena. J Physiol. 1998;506(2):579\u201387.","journal-title":"J Physiol"},{"issue":"8","key":"924_CR12","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1038\/ajg.2017.129","volume":"112","author":"J Malagelada","year":"2017","unstructured":"Malagelada J, Accarino A, Azpiroz F. Bloating and abdominal distension: old misconceptions and current knowledge. Am J Gastroenterol. 2017;112(8):1221\u201331.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"924_CR13","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1053\/j.gastro.2006.07.015","volume":"131","author":"L Houghton","year":"2006","unstructured":"Houghton L, Lea R, Agrawal A, Reilly B, Whorwell P. Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit. Gastroenterology. 2006;131(4):1003\u201310.","journal-title":"Gastroenterology"},{"issue":"8","key":"924_CR14","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1038\/ajg.2009.251","volume":"104","author":"A Agrawal","year":"2009","unstructured":"Agrawal A, Houghton L, Reilly B, Morris J, Whorwell P. Bloating and distension in irritable bowel syndrome: the role of gastrointestinal transit. Am J Gastroenterol. 2009;104(8):1998\u20132004.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"924_CR15","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1365-2036.2008.03881.x","volume":"29","author":"D Drossman","year":"2009","unstructured":"Drossman D, Chey W, Johanson J, et al. Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome\u2014results of two randomized, placebo-controlled studies. Aliment Pharmacol Ther. 2009;29(3):329\u201341.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"924_CR16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1365-2036.2011.04983.x","volume":"35","author":"W Chey","year":"2012","unstructured":"Chey W, Drossman D, Johanson J, Scott C, Panas R, Ueno R. Safety and patient outcomes with lubiprostone for up to 52\u00a0weeks in patients with irritable bowel syndrome with constipation. Aliment Pharmacol Ther. 2012;35(5):587\u201399.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"924_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/apt.12123","volume":"37","author":"E Quigley","year":"2012","unstructured":"Quigley E, Tack J, Chey W, et al. Randomised clinical trials: linaclotide phase 3 studies in IBS-C\u2014a prespecified further analysis based on European Medicines Agency-specified endpoints. Aliment Pharmacol Ther. 2012;37(1):49\u201361.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"924_CR18","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/ajg.2010.54","volume":"105","author":"L Shim","year":"2010","unstructured":"Shim L, Prott G, Hansen R, Simmons L, Kellow J, Malcolm A. Prolonged balloon expulsion is predictive of abdominal distension in bloating. Am J Gastroenterol. 2010;105(4):883\u20137.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"924_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1053\/gast.1997.v113.pm9247458","volume":"113","author":"A Accarino","year":"1997","unstructured":"Accarino A, Azpiroz F, Malagelada J. Attention and distraction: effects on gut perception. Gastroenterology. 1997;113(2):415\u201322.","journal-title":"Gastroenterology"},{"issue":"1","key":"924_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/gutjnl-2012-302167","volume":"62","author":"M Simr\u00e9n","year":"2012","unstructured":"Simr\u00e9n M, Barbara G, Flint H, et al. Intestinal microbiota in functional bowel disorders: a Rome Foundation report. Gut. 2012;62(1):159\u201376.","journal-title":"Gut"},{"issue":"12","key":"924_CR21","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.dld.2009.07.023","volume":"41","author":"S Collins","year":"2009","unstructured":"Collins S, Denou E, Verdu E, Bercik P. The putative role of the intestinal microbiota in the irritable bowel syndrome. Dig Liver Dis. 2009;41(12):850\u20133.","journal-title":"Dig Liver Dis"},{"issue":"9","key":"924_CR22","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/sj.ejcn.1601651","volume":"57","author":"P Vernia","year":"2003","unstructured":"Vernia P, Camillo M, Marinaro V, Caprilli R. Effect of predominant methanogenic flora on the outcome of lactose breath test in irritable bowel syndrome patients. Eur J Clin Nutr. 2003;57(9):1116\u20139.","journal-title":"Eur J Clin Nutr"},{"issue":"3","key":"924_CR23","doi-asserted-by":"publisher","first-page":"318","DOI":"10.5009\/gnl14344","volume":"9","author":"SMP Bennet","year":"2015","unstructured":"Bennet SMP, Ohman L, Simren M. Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver. 2015;9(3):318\u201331.","journal-title":"Gut Liver"},{"issue":"6","key":"924_CR24","doi-asserted-by":"publisher","first-page":"G417","DOI":"10.1152\/ajpgi.00044.2015","volume":"310","author":"T Ringel-Kulka","year":"2016","unstructured":"Ringel-Kulka T, Benson A, Carroll I, Kim J, Legge R, Ringel Y. Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating. Am J Physiol Gastrointest Liver Physiol. 2016;310(6):G417\u201326.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"6","key":"924_CR25","doi-asserted-by":"publisher","first-page":"e389","DOI":"10.1111\/nmo.12128","volume":"25","author":"E Barba","year":"2013","unstructured":"Barba E, Quiroga S, Accarino A, et al. Mechanisms of abdominal distension in severe intestinal dysmotility: abdomino-thoracic response to gut retention. Neurogastroenterol Motil. 2013;25(6):e389\u201394.","journal-title":"Neurogastroenterol Motil"},{"key":"924_CR26","first-page":"241","volume":"4","author":"DG Maxton","year":"1992","unstructured":"Maxton DG, Whorwell PJ. Abdominal distension in irritable bowel syndrome: the patient\u2019s perception. Eur Hepatol. 1992;4:241\u20133.","journal-title":"Eur Hepatol"},{"issue":"2","key":"924_CR27","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1136\/gut.48.2.216","volume":"48","author":"M Lewis","year":"2001","unstructured":"Lewis M. Ambulatory abdominal inductance plethysmography: towards objective assessment of abdominal distension in irritable bowel syndrome. Gut. 2001;48(2):216\u201320.","journal-title":"Gut"},{"key":"924_CR28","first-page":"112","volume":"3","author":"AC Dukowicz","year":"2007","unstructured":"Dukowicz AC, Lacy BE, Levine GM. Small intestinal bacterial overgrowth: a comprehensive review. Gastroenterol Hepatol. 2007;3:112\u201322.","journal-title":"Gastroenterol Hepatol"},{"issue":"11","key":"924_CR29","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/j.1552-4604.1974.tb01382.x","volume":"14","author":"J Bernstein","year":"1974","unstructured":"Bernstein J, Kasich A. A double-blind trial of simethicone in functional disease of the upper gastrointestinal tract. J Clin Pharmacol. 1974;14(11):617\u201323.","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"924_CR30","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/BF02936952","volume":"32","author":"J Liu","year":"1997","unstructured":"Liu J, Chen G, Yeh H, Huang C, Poon S. Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial. J Gastroenterol. 1997;32(6):765\u20138.","journal-title":"J Gastroenterol"},{"issue":"6","key":"924_CR31","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.dld.2007.02.006","volume":"39","author":"G Cappello","year":"2007","unstructured":"Cappello G, Spezzaferro M, Grossi L, Manzoli L, Marzio L. Peppermint oil (Mintoil\u00ae) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial. Dig Liver Dis. 2007;39(6):530\u20136.","journal-title":"Dig Liver Dis"},{"issue":"1","key":"924_CR32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1053\/j.gastro.2013.09.046","volume":"146","author":"E Halmos","year":"2014","unstructured":"Halmos E, Power V, Shepherd S, Gibson P, Muir J. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology. 2014;146(1):67\u201375.","journal-title":"Gastroenterology"},{"issue":"3","key":"924_CR33","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3390\/nu9030292","volume":"9","author":"G Catassi","year":"2017","unstructured":"Catassi G, Lionetti E, Gatti S, Catassi C. The low FODMAP diet: many question marks for a catchy acronym. Nutrients. 2017;9(3):292.","journal-title":"Nutrients"},{"issue":"5","key":"924_CR34","doi-asserted-by":"publisher","first-page":"G942","DOI":"10.1152\/ajpgi.00264.2005","volume":"290","author":"M Camilleri","year":"2006","unstructured":"Camilleri M, Bharucha A, Ueno R, et al. Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers. Am J Physiol Gastrointest Liver Physiol. 2006;290(5):G942\u20137.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"924_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/nmo.12217","volume":"26","author":"J Tack","year":"2013","unstructured":"Tack J, Stanghellini V, Dubois D, Joseph A, Vandeplassche L, Kerstens R. Effect of prucalopride on symptoms of chronic constipation. Neurogastroenterol Motil. 2013;26(1):21\u20137.","journal-title":"Neurogastroenterol Motil"},{"issue":"6","key":"924_CR36","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1053\/j.gastro.2013.08.017","volume":"145","author":"J Castro","year":"2013","unstructured":"Castro J, Harrington A, Hughes P, et al. Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3\u2032,5\u2032-monophosphate. Gastroenterology. 2013;145(6):1334\u20131346.e11.","journal-title":"Gastroenterology"},{"key":"924_CR37","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1056\/NEJMoa1010863","volume":"365","author":"AJ Limbo","year":"2011","unstructured":"Limbo AJ, Schneier HA, Shiff SJ, et al. Two randomized trials of linaclotide for chronic constipation. N Engl J Med. 2011;365:527\u201336.","journal-title":"N Engl J Med"},{"key":"924_CR38","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1038\/ajg.2012.255","volume":"107","author":"S Rao","year":"2012","unstructured":"Rao S, Lembo AJ, Shiff SJ, et al. A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation. Am J Gastroenterol. 2012;107:1714\u201324.","journal-title":"Am J Gastroenterol"},{"key":"924_CR39","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1038\/ajg.2012.254","volume":"107","author":"WD Chey","year":"2012","unstructured":"Chey WD, Lembo AJ, Lavins BJ, et al. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety. Am J Gastroenterol. 2012;107:1702\u201312.","journal-title":"Am J Gastroenterol"},{"key":"924_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/apt.12123","volume":"37","author":"EMM Quigley","year":"2013","unstructured":"Quigley EMM, Tack J, Chey WD, et al. Randomised clinical trials: linaclotide phase 3 studies in IBS-C\u2014a prespecified further analysis based on European Medicines Agency-specified endpoints. Aliment Pharmacol Ther. 2013;37:49\u201361.","journal-title":"Aliment Pharmacol Ther"},{"key":"924_CR41","doi-asserted-by":"publisher","first-page":"e0134349","DOI":"10.1371\/journal.pone.0134349","volume":"10","author":"BE Lacy","year":"2015","unstructured":"Lacy BE, Schey R, Shiff SJ, et al. Linaclotide in chronic idiopathic constipation patients with moderate to severe abdominal bloating: a randomized, controlled trial. PLoS One. 2015;10:e0134349.","journal-title":"PLoS One"},{"issue":"9","key":"924_CR42","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.cgh.2013.04.032","volume":"11","author":"E Videlock","year":"2013","unstructured":"Videlock E, Cheng V, Cremonini F. Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constipation: a meta-analysis. Clin Gastroenterol Hepatol. 2013;11(9):1084\u20131092.e3.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"924_CR43","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1053\/gast.2002.33658","volume":"122","author":"M Caldarella","year":"2002","unstructured":"Caldarella M, Serra J, Azpiroz F, Malagelada J. Prokinetic effects in patients with intestinal gas retention. Gastroenterology. 2002;122(7):1748\u201355.","journal-title":"Gastroenterology"},{"issue":"8","key":"924_CR44","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1111\/j.1572-0241.2008.01866.x","volume":"103","author":"A Accarino","year":"2008","unstructured":"Accarino A, Perez F, Azpiroz F, Quiroga S, Malagelada J. Intestinal gas and bloating: effect of prokinetic stimulation. Am J Gastroenterol. 2008;103(8):2036\u201342.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"924_CR45","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJMoa1004409","volume":"364","author":"M Pimentel","year":"2011","unstructured":"Pimentel M, Lembo A, Chey W, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011;364(1):22\u201332.","journal-title":"N Engl J Med"},{"issue":"2","key":"924_CR46","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1572-0241.2006.00458.x","volume":"101","author":"A Sharara","year":"2006","unstructured":"Sharara A, Aoun E, Abdul-Baki H, Mounzer R, Sidani S, ElHajj I. A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence. Am J Gastroenterol. 2006;101(2):326\u201333.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"924_CR47","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/gut.2008.167270","volume":"59","author":"P Moayyedi","year":"2008","unstructured":"Moayyedi P, Ford A, Talley N, et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut. 2008;59(3):325\u201332.","journal-title":"Gut"},{"key":"924_CR48","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1365-2036.2007.03480.x","volume":"26","author":"D Jonkers","year":"2007","unstructured":"Jonkers D, Stockbr\u00fcgger R. Review article: probiotics in gastrointestinal and liver diseases. Aliment Pharmacol Ther. 2007;26:133\u201348.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"924_CR49","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.giec.2008.12.004","volume":"19","author":"Y Ringel","year":"2009","unstructured":"Ringel Y, Carroll I. Alterations in the intestinal microbiota and functional bowel symptoms. Gastrointest Endosc Clin N Am. 2009;19(1):141\u201350.","journal-title":"Gastrointest Endosc Clin N Am"},{"issue":"6","key":"924_CR50","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/MCG.0b013e31820ca4d6","volume":"45","author":"T Ringel-Kulka","year":"2011","unstructured":"Ringel-Kulka T, Palsson O, Maier D, et al. Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders. J Clin Gastroenterol. 2011;45(6):518\u201325.","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"924_CR51","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1053\/j.gastro.2014.12.006","volume":"148","author":"E Barba","year":"2015","unstructured":"Barba E, Burri E, Accarino A, et al. Abdominothoracic mechanisms of functional abdominal distension and correction by biofeedback. Gastroenterology. 2015;148(4):732\u20139.","journal-title":"Gastroenterology"},{"issue":"8","key":"924_CR52","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1136\/gut.2005.077503","volume":"55","author":"J Tack","year":"2005","unstructured":"Tack J. A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome. Gut. 2005;55(8):1095\u2013103.","journal-title":"Gut"},{"issue":"1","key":"924_CR53","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.pnpbp.2008.10.018","volume":"33","author":"R Rahimi","year":"2009","unstructured":"Rahimi R, Nikfar S, Abdollahi M. Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(1):118\u201327.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"924_CR54","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0016-5085(03)00669-3","volume":"125","author":"D Drossman","year":"2003","unstructured":"Drossman D, Toner B, Whitehead W, et al. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology. 2003;125(1):19\u201331.","journal-title":"Gastroenterology"},{"issue":"10","key":"924_CR55","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/j.1365-2036.2011.04637.x","volume":"33","author":"M Schmulson","year":"2011","unstructured":"Schmulson M, Chang L. Review article: the treatment of functional abdominal bloating and distension. Aliment Pharmacol Ther. 2011;33(10):1071\u201386.","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-00924-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-019-00924-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-019-00924-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,15]],"date-time":"2020-03-15T00:04:12Z","timestamp":1584230652000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-019-00924-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,16]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["924"],"URL":"https:\/\/doi.org\/10.1007\/s12325-019-00924-7","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,16]]},"assertion":[{"value":"5 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}